Division of Research
BioSafety (IBC) and rDNA Research
The purpose of the IBC is to ensure that the NIH Guidelines for Research Involving Recombinant DNA Molecules are adhered to at FIU. Recombinant DNA molecules are defined by NIH guidelines as either: (i) molecules that are constructed outside living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell, or (ii) molecules that result from the replication of those described in (i) above. See thesection "Definition of Recombinant DNA Molecules" for further detail.
FIU requires that all use of recombinant DNA at the University be registered with the Institutional Biosafety Committee, even if the use is as simple as the cloning of allelic PCR products prior to sequencing. In many cases this process will be as simple as filling out a form indicating that the type of recombinant work being carried out in your lab is exempt from NIH guidelines.
| Office Address: | Mailing Address: |
|---|---|
| Florida International University Office of Research Integrity Modesto A. Maidique Campus (MMC) MARC 270 Miami, Florida 33199 |
Florida International University Office of Research Integrity Modesto A. Maidique Campus (MMC) MARC 430 Miami, Florida 33199 |
Contact:
Barbara Llaneras Rodriguez, IBC Coordinator
Kathleen Rein, IBC Chairperson
